Rituximab in the treatment of autoimmune haematological disorders

British Journal of Haematology

Volumn 143, Issue 2, 2008, Pages 294-

  Provan, Drew ^a   Newland, Adrian C ^a   Amadori, Sergio ^b   Stasi, Roberto ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^c REGINA APOSTOLORUM HOSPITAL   (Italy)

Author keywords

Anti CD20; Autoimmune disease; ITP; Low dose; Rituximab

Indexed keywords

RITUXIMAB;

ABSENCE OF SIDE EFFECTS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; HEMATOLOGIC DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LETTER; LOW DRUG DOSE; NEUTROPENIA; NONHODGKIN LYMPHOMA; OFF LABEL DRUG USE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; HEMATOLOGIC DISEASES; HUMANS; IMMUNOLOGIC FACTORS;

EID: 52649158145     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07326.x     Document Type: Letter

References (4)

1. El-Najjar, I., Rule, S.A.J. Nokes, T.J.C 2006) A fixed, low dose of anti-CD20 antibody (rituximab) is an effective treatment for patients with chronic immune thrombocytopenia. British Journal of Haematology, 133, 79 (Abstract 196).
2. Garvey, B. (2008) Rituximab in the treatment of autoimmune haematological disorders. British Journal Haematology, 141, 149 169.
3. McLaughlin, P., Grillo-Lopez, A.J., Link, B.K., Levy, R., Czuczman, M.S., Williams, M.E., Heyman, M.R., Bence-Bruckler, I., White, C.A., Cabanillas, F., Jain, V., Ho, A.D., Lister, J., Wey, K., Shen, D. Dallaire, B.K. (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of Clinical Oncology, 16, 2825 2833.
4. Provan, D., Butler, T., Evangelista, M.L., Amadori, S., Newland, A.C. Stasi, R. (2007) Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults. Haematologica, 92, 1695 1698.